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Abstract 
 
Aging is a major risk factor for the development of cardiovascular disease. Despite a 
significant reduction in the mortality and morbidity rates over the last decade, the 
socio-economic burden of cardiovascular disease is still substantial. Consequently, 
there is a considerable need for alternative strategies, such as nutraceutical 
supplementation, that delay the functional vascular decline present in the elderly. 
Compromised autophagy and oxidative stress (OS) are considered major causes of 
the age-related endothelial dysfunction. OS reduces the bioavailability of nitric oxide 
(NO), which has been associated with hypertension, arteriosclerosis and a reduced 
vasodilatory response. High levels of free radicals and the low bioavailability of NO 
lead to a positive feedback loop of further OS, organelle damage, poor repair and 
endothelial dysfunction. Here we draw attention to the relationship between OS and 
autophagy in the aged vasculature. We have reviewed the published literature and 
provided arguments that support that treatment with resveratrol stimulates 
autophagy and thereby has the potential to restore oxidative balance in the 
endothelium, which indicates that treatment with resveratrol might have 
therapeutic potential to restore endothelial function in the elderly.  
 
Keywords: Antioxidant; Autophagy; Endothelium; Oxidative Stress. 
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1. Introduction 
 
Advances in medicine have allowed humans to become older. Life expectancy in 
developed countries is now on average 70 years and it is estimated that by 2030 
20% of the world’s population will be older than 65 years (North and Sinclair, 
2012). However, aging is associated with a steady and rapid physiological decline. 
Aging, for instance, is a major risk factor for the development of cardiovascular 
disease. In 2014, cardiovascular disease was the second most common cause of 
death in the UK with approximately 155,000 deaths (Cardiovascular Disease 
Statistics 2015). Despite a significant reduction in the mortality and morbidity rates 
over the last decade, the socio-economic burden of cardiovascular disease is still 
substantial (Bhatnagar et al., 2015). Consequently, there is a considerable need for 
alternative strategies such as nutraceutical supplementation that delay the 
functional decline present in old age.    
 
The aged vasculature is characterized by increased arterial thickness, stiffness and 
endothelial dysfunction. Such structural and functional changes result in 
hypertension, arteriosclerosis, stroke, poor tissue perfusion, among other 
pathological conditions (North and Sinclair, 2012). At the molecular level, aging is 
characterized by a reduced bioavailability of nitric oxide (NO), increased production 
of collagen by vascular smooth muscle cells, and changes in the expression of 
proteins that regulate calcium handling (Strait and Lakatta, 2012). NO plays a 
pivotal role in endothelium-dependent dilation. Further, NO is critical for the 
prevention of thrombosis and inhibition of platelet aggregation (Tousoulis et al., 
2006; Vora et al., 1997). Hence, a reduced bioavailability of NO is associated with 
endothelial dysfunction. One of the most important factors affecting NO synthesis in 
the aged vasculature is oxidative stress (OS). Within the endothelial cell, cumulative 
oxidative damage leads to organelle dysfunction, and compromised repair or 
renewal (Irani, 2000).  
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In this regard, resveratrol (RV) has received considerable attention during the last 
decade. RV is a naturally occurring polyphenol found mostly in the skin of red 
grapes, peanuts, and blackberries (Li et al., 2012). Flow-mediated dilation (FMD) 
refers to the changes in vessel diameter caused by increases in shear stress. FMD is 
considered a surrogate of endothelial function and in humans is measured by 
ultrasound in superficial arteries such as the brachial and femoral arteries (Currie et 
al., 2014). A growing body of evidence suggests that RV improves FMD (Wong et al., 
2013), reduces  blood pressure (BP), the circulating levels of inflammatory 
molecules (Timmers et al., 2011), and myocardial damage during ischemia-
reperfusion (Bradamante et al., 2004). The mechanisms by which RV confers 
vascular protection involve a higher biosynthesis of NO, increases in the activity of 
proteins that regulate oxidative metabolism, increases in the activity several 
antioxidant enzymes, as well as the stimulation of cellular self-repair processes 
(collectively known as autophagy) within the endothelial cell. Consequently, RV has 
become an attractive candidate in nutraceutical strategies that aim to improve 
vascular function in the elderly 
 
Here we review how cumulative oxidative damage and impaired autophagy in old 
age might contribute to endothelial dysfunction. We discuss the potential of RV to 
protect against oxidative assault, promote autophagy and restore endothelial 
function in old vessels.  
  
2. The vascular endothelium 
 
The endothelium is a monolayer of cells that lines blood vessels and is the only 
cellular layer that separates the blood from surrounding tissue in capillaries. It acts 
as a permeable barrier to solutes and macromolecules, and is critical not only in the 
regulation of vessel diameter, but also in coagulation, angiogenesis and 
inflammation. Endothelial cells modulate vascular tone by releasing vasoactive 
molecules, such as NO (Furchgott and Vanhoutte, 1989). NO activates cGMP-
dependent protein kinase, which induces vasodilation and prevents platelet 
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aggregation (McHugh and Cheek, 1998). Furthermore, NO enhances oxidative 
metabolism and oxygen consumption (Clementi et al., 1999; Parihar et al., 2008), 
and protects against ischemia-reperfusion injury and oxidative damage (Crouser, 
2004; Gourine et al., 2002; Rakhit et al., 2001). 
Under normal conditions, the vascular endothelium regulates arterial tone and 
blood flow to match the needs of the tissue. Vascular dysfunction is evident when 
either the release of, or the response to vasodilators is blunted. For instance, 
overproduction of vasoconstrictors with a reduced bioavailability of relaxing 
factors, such as NO, will lead to an increased vascular tone (Lerman and Burnett, 
1992). During aging, the higher secretion of endothelial cell-derived pro-
inflammatory and thrombogenic factors eventually results in irregular 
vasoreactivity and partial loss of endothelial function (Verma and Anderson, 2002), 
which underlies the increased prevalence of cardiovascular problems in old age. 
 
There is evidence that OS and mitochondrial dysfunction play a significant role in 
the age-related onset of endothelial dysfunction (Brandes et al., 2005). OS will over 
time result in an accumulation of molecules modified by reactive oxygen and 
nitrogen species, which leads to compromised organelle and ultimately cell and 
tissue function. One of the mechanisms whereby the cell protects itself from the 
accumulation of oxidatively modified protein and dysfunctional organelles is 
autophagy. During autophagy, pathogens, dysfunctional organelles and harmful 
cytoplasmic constituents are sequestered into vesicles, autophagosomes, and fused 
with the lysosome for degradation and recycling (Kroemer et al., 2010).  
 
3. Oxidative stress, autophagy and the aged vasculature 
 
The capacity of the vessel to dilate in response to increased flow or vasodilating 
agents diminishes with age (Brandes et al., 2005). Part of the problem is related to a 
disturbed regulation of release of vasodilatory and vasoconstricting factors from the 
endothelial cells. Many factors contribute to age-related endothelial dysfunction. 
Among those are decreased circulatory levels of growth factors and vasodilators, 
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increased circulatory levels of vasoconstrictors and inflammation (Csiszar et al., 
2004; Daiber et al., 2016). Today, it is widely accepted that OS plays a pivotal role in 
age-related endothelial dysfunction (Brandes et al., 2005). Scavenging of free 
radicals is necessary for the appropriate functioning of the endothelium. With age, 
increased production of the anion superoxide (O2-) has been suggested to lead to a 
reduced bioavailability of NO, as O2- will scavenge NO to produce peroxynitrite 
(ONOO−) (Blackwell et al., 2004; Ferrer et al., 2003; Hamilton et al., 2001; 
Rodríguez-Mañas et al., 2009; van der Loo et al., 2000). The main sources of 
endothelium-derived O2- appear to be the mitochondrion, NADPH oxidase and 
endothelial nitric oxide synthase (eNOS) itself (Hamilton et al., 2001). 
Tetrahydrobiopterin (BH4) is an essential cofactor for the NO synthases. In high 
concentrations, ONOO− oxidizes BH4. In the absence of BH4, the NO synthases 
become uncoupled and produce O2-, which leads to further production of ONOO− 
and OS (Golbidi and Laher, 2013).  
 
As mentioned above, aging is a major risk factor for the development of 
cardiovascular disease. The molecular and morphological profiles of the aged 
endothelial cell correspond to a state of disturbed homeostasis and poor repair 
(LaRocca et al., 2013). Considering that autophagy is reduced during aging and the 
close association between autophagy and OS, there is reason to believe that the 
inability to maintain autophagy is instrumental, if not critical, for the OS-induced 
endothelial dysfunction in old age (Lee et al., 2012). Autophagy is involved in the 
expression of eNOS under steady laminar shear stress (Guo et al., 2014). Endothelial 
cells with knockdown of autophagy related protein (Atg) 3 display significantly 
lower levels of eNOS phosphorylation and are not able to produce NO in response to 
shear stress. This is accompanied by higher levels of reactive oxygen species (ROS) 
and inflammation as indicated by the increase in monocyte chemoattractant 
protein-1 and interleukin 8 (IL-8) (Bharath et al., 2014). The reduced bioavailability 
of NO and subsequent compromise of endothelial function has been associated with 
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pathological conditions such as hypertension and atherosclerosis (Eren et al., 2013; 
Münzel et al., 2008).  
 
Significant build-up of oxidative by-products results in endothelial cell death. 
However, such accumulation is largely prevented by autophagy. 4-hydroxynonenal 
(4-HNE) and acrolein, products of lipid peroxidation, have been shown to strongly 
induce autophagy in endothelial cells from Sprague–Dawley rat aortic explants. 
Further, failure to remove aldehyde-modified proteins by inhibiting autophagy 
accelerates aging and cell death (Hill et al., 2008; LaRocca et al., 2012). The 
importance of autophagy is indicated in these studies by a robust increase of 
microtubule-associated protein 1 light chain 3 II (LC3II) and significant 
vacuolization, formation of pinocytic bodies, crescent-shaped phagophores and 
multilamellar vesicles, all morphological characteristics of autophagy. (Hill et al., 
2008; LaRocca et al., 2012). Thus, it is possible that the inability to maintain 
autophagy is responsible for the OS-induced endothelial dysfunction in old age. 
 
Recently, LaRocca et al (2012), demonstrated in a compelling study that the decline 
in endothelial function in elderly subjects depends on NO availability. Further, that 
endothelial dysfunction is associated with higher circulating levels of oxidized low-
density lipoprotein, IL-6 and C-reactive protein, and a reduced expression of beclin-
1, a critical protein in the initiation of autophagy, in endothelial cells isolated from 
the brachial artery of these subjects. Similar to their findings in humans, their 
experiments on the aorta and carotid arteries from aged C57BL/6 mice revealed 
significantly lower endothelium-dependent dilation in response to acetylcholine 
when compared to young controls. As expected, this was consistent with a reduced 
expression of eNOS, beclin 1, LC3II, WD repeat domain phosphoinositide-interacting 
protein 1 (WIPI-1; a key mediator of autophagy), and markedly greater levels of 
O2. Interestingly, when the mice were supplemented, or the cultured cells treated 
with trehalose, a natural disaccharide that promotes autophagy, endothelial-
dependent dilation and all markers of autophagy and OS were restored to the levels 
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of controls. In a similar study, they proceeded to test the effects of spermidine, a 
natural polyamine that strongly induces autophagy (LaRocca et al., 2013). As 
hypothesized, treatment with spermidine enhanced autophagy, reversed elastic 
stiffening of the aorta, restored endothelial-dependent dilation and reduced OS in 
old mice (LaRocca et al., 2013). Collectively, their findings provide strong evidence 
on the role that OS and impaired organelle turnover play in endothelial dysfunction 
during aging. 
In addition to the increased production of free radicals, substantial evidence 
suggests that the reduction in antioxidant enzymes is also responsible for higher 
levels of OS in old age. In the aorta and femoral artery of rats, aging has been 
associated with a decrease in the activity of superoxide dismutase (SOD) and 
increased nitration of manganese superoxide dismutase (MnSOD) (Barton et al., 
1997; Durrant et al., 2009; van der Loo et al., 2000; Zanetti et al., 2010). Evidence 
that the decline in antioxidant enzymes and a higher production of free radicals are 
associated with aging comes from MnSOD knockout models in which the animals 
suffered from age-dependent OS, endothelial dysfunction and cardiomyopathy 
(Ohashi et al., 2006; Roos et al., 2013; Strassburger et al., 2005; Wenzel et al., 2008). 
Further, treatment with the SOD mimetic Tempol restored endothelium-dependent 
dilation, and prevented the formation of atheroma plaques (Cannizzo et al., 2014; 
Lesniewski et al., 2009; Tatchum-Talom and Martin, 2004). Taken together, these 
data corroborate the effect of free radicals, particularly O2- on the age-related 
endothelial dysfunction in humans and other animals. 
 
4. The use of antioxidants  
 
Considering the deleterious effects that cumulative oxidative damage causes in the 
vasculature, significant attention has been given during the last decade to the 
potential of antioxidants to restore oxidative balance (Conti et al., 2016). The role 
that free radicals play on such a broad spectrum of physiological functions has 
fueled the passionate debate on the potential beneficial effects of antioxidant 
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supplementation. As elegantly explained by Bast and Haenen (Bast and Haenen, 
2013), the expectations for antioxidants have been so high that the results so far 
have been somewhat confusing and disappointing. As mentioned above, RV has 
received extensive attention in this regard. As an antioxidant, RV scavenges O2-  
and the hydroxyl radical (OH), increases the activity of several antioxidant 
enzymes and protects lipid membranes and DNA from peroxidation and strand-
breaks, respectively (Cao and Li, 2004; Leonard et al., 2003). In addition to its 
antioxidant effects, RV increases the activity of eNOS (Wallerath et al., 2002) and 
confers anti-inflammatory protection (Ungvari et al., 2009), which makes it an 
attractive candidate to reverse the age-related structural and functional changes in 
the blood vessel.  
 
5. Considerations for the use of resveratrol  
 
Thus far, most studies have focused on sirtuin 1 (SIRT1) as the key target of RV. 
Sirtuins are NAD+-dependent protein deacetylases that regulate 
oxidative metabolism. SIRT1 in particular is localized in the nucleus and has been 
shown to increase the activity of catalase and prevent apoptosis in human 
endothelial cells (Alcendor et al., 2007; Li et al., 2015). However, a growing body of 
evidence indicates that other important signaling pathways convey the antioxidant 
and anti–inflammatory properties of RV. Such pathways include the activation of 
peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) via 
AMP-activated protein kinase (AMPK) (Baur et al., 2006; Lagouge et al., 2006; 
Olesen et al., 2014a; Ungvari et al., 2009), as well as the down-regulation nuclear 
factor κB (NF-κB), which signals pro-inflammatory responses in aging (Ungvari et 
al., 2009, 2007). In addition, the induction of the transcription factor erythroid 2-
related factor 2 (Nrf2) is responsible for some of the antioxidant and anti-
inflammatory effects of RV on the endothelial cells. Upon activation, Nfr2 induces 
the expression of genes coding for important enzymes involved in antioxidant 
processes such as NADPH:quinone oxidoreductase 1, heme oxygenase-1, and γ-
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glutamylcysteine synthetase (Ungvari et al., 2010). On the other hand, 
downregulation of Nfr2 prevents the RV-induced protection from OS in human 
coronary arteries and impairs the dilation in response to acetylcholine in the 
arterioles in the gracilis muscle of aged mice (Ungvari et al., 2010).  
 
Some of the initial enthusiasm for the nutraceutical potential of antioxidants has 
faded. This, mostly because we now understand that ROS serve a broad range of 
physiological functions. Under controlled balance free radicals regulate homeostasis 
and physiological angiogenesis (Bir et al., 2012). Furthermore, hydrogen peroxide 
(H202) stimulates cell proliferation (Simon and Stutzin, 2008), promotes the 
secretion of growth factors (Chua et al., 1998; Colavitti et al., 2002; González-
Pacheco et al., 2006), regulates apoptosis (Chen et al., 2004) and acts as a 
vasodilating agent in human coronary arterioles (Zhang et al., 2012). Recent 
evidence suggests that the H202-induced dimerization of cGMP-dependent protein 
kinase (PKG)-Iα leads to the opening of calcium-activated potassium channels and 
further dilation of the vessel (Zhang et al., 2012). Hence, the paradigm that ‘the 
more antioxidants the better’ is now changing to a complementary strategy aimed to 
normalize the production of free radicals (Bast and Haenen, 2013). Regarding the 
effects of RV on the vascular endothelium in old age, conflicting data between 
humans and other species have been published. For instance, RV has been shown to 
reverse oxidative damage by reducing the expression of NADPH oxidase while 
increasing the expression of SIRT1 in the aorta of aged rats (Tang et al., 2012). In the 
cardiovascular system, the reduced expression of SIRT1 is specifically limited to 
aged and/or atherosclerotic vessels (Kao et al., 2010). Also, it has been 
demonstrated that RV prevents free radical-induced senescence in human umbilical 
vein endothelial cells (HUVECs) but fails to protect from oxidative damage when the 
gene for SIRT1 is silenced (Kao et al., 2010). 
 
Some of the benefits of RV are mediated by stimulation of autophagy. Treatment of 
HUVECs with RV up-regulated the expression of sequestosome 1 (SQSMT1), an 
autophagosome cargo protein that selectively targets proteins for autophagy, eNOS, 
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SIRT1, and several genes related to autophagy including LC3B and AGT3 (Chen et al., 
2013; Takizawa et al., 2013). In support of such protective effects, RV has also been 
shown to preserve telomere length and increase telomerase activity in aortic rings 
from aged rats (da Luz et al., 2012a). Of particular interest is the fact that 
endothelium-dependent dilation improved significantly after treatment with RV for 
six months (da Luz et al., 2012b). Recently, a causal relationship between the levels 
of the mammalian target of rapamycin (mTOR) and the ribosomal protein S6 kinase 
beta-1 (S6K1), and vascular aging was reported. Over activation of this pathway 
leads to aging-related disorders including cardiovascular disease (Stanfel et al., 
2009). The activity of S6K1 is higher in aortic rings of old rats and in cultured 
senescent human endothelial cells (Rajapakse et al., 2011). Related to this, there is a 
higher production of free radicals and a concomitant reduced synthesis of NO. 
Treatment of the cells for one hour with RV restored excess production of 
mitochondrial O2- and enhanced the synthesis of NO in response to acetylcholine 
(Rajapakse et al., 2011).  
 
Recent studies in humans, by contrast, suggest that in aged, but healthy individuals 
RV blunts the positive cardiovascular effects of physical exercise (Gliemann et al., 
2014, 2013; Olesen et al., 2014b). When submitted to eight weeks of high intensity 
training and a daily intake of either 250 mg of RV or placebo, the subjects that 
received RV showed no increase in the capillary-to-fiber ratio or the concentration 
of vascular endothelial growth factor in the vastus lateralis. Further, 
supplementation with RV inhibited the exercise-induced reduction in BP and blood 
lipids and attenuated the gains in maximal oxygen consumption observed in the 
group that exercised under the placebo. Likewise, no changes were reported in 
markers of metabolic and inflammation status such as 3-hydroxyacyl-CoA 
dehydrogenase, cytochrome c oxidase I, PCG-1, SIRT1, and TNF. Finally, in 
HUVECs, RV inhibited cell migration and capillary tube formation by enhancing the 
nuclear translocation of the transcription factors forkhead box O (FOXO)1, FOXO3a 
and FOXO4 (Srivastava et al., 2010). Clearly, these results cast some doubt on the 
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current paradigm that RV mimics the metabolic and anti-inflammatory effects of 
exercise and caloric restriction that promote cardiovascular health. The studies in 
humans, particularly in the elderly, are still only a handful when compared to those 
in rodents. However, as will be discussed below they call for caution when 
attributing to RV, or any anti-oxidant for that matter, exceptional therapeutic 
properties. Table 1 summarizes the studies on the effects of RV on the blood vessel. 
Figure 1 shows some of the mechanisms by which RV confers vascular protection. 
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6. Perspective 
 
Even though some might deem the therapeutic potential of RV to be overstated, we 
believe that the data published thus far reflect clinical promise. Healthy populations 
might not experience positive metabolic or cardiovascular effects after treatment 
with RV. Yet, there is no clinical justification to treat those subjects or expect such 
effects. Moreover, it is not clear how positive effects in an already healthy 
population should be interpreted (Smoliga et al., 2013). On the other hand, enough 
evidence has been gathered to suggest that compromised populations such as the 
elderly do benefit from treatment with RV (Smoliga et al., 2013). Even though a 
recent series of publications in aged humans (Gliemann et al., 2014, 2013; Olesen et 
al., 2014b) reveals no benefit from RV supplementation in a broad range of 
cardiovascular and metabolic parameters, further research needs to be conducted to 
definitely validate the claims both in favor and against RV. 
 
We have discussed here how RV scavenges free radicals, increases antioxidant 
activity, and promotes autophagy and the synthesis of proteins central to oxidative 
metabolism in aged vessels. We have also highlighted the fact that free radicals 
serve as signaling molecules and as such, a controlled production is necessary for 
adequate functioning of the blood vessel. Interestingly, supplementation with thiol-
based and other antioxidants such as tocopherol prevents ROS-induced autophagy 
(Underwood et al., 2010). With that in mind, some have questioned whether a 
higher production of free radicals during aging is in fact detrimental to 
cardiovascular health (Gliemann et al., 2013). Some evidence suggests that in 
mammalian cultured cells NO, a free radical, inhibits autophagy by nitrosylation of 
c-Jun N-terminal kinase 1. This ultimately leads to the disruption of the Beclin/1–
hVps34 complex, which is necessary during autophagosome formation (Sarkar et al., 
2011). At first, these findings might seem in direct contrast to some of the reports 
discussed above. However, it is worth mentioning at this point that the production 
of free radicals, degradation of proteins and organelles via autophagy and the 
synthesis of antioxidants enzymes can be either beneficial or detrimental depending 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
14 | P a g e  
 
on the energy and redox status of the cell. Different oxidative modifications are 
particular to different types of free radicals in the same way that different 
antioxidants scavenge different ROS. For instance, during nutrient deprivation the 
cell promotes an oxidative environment by expelling glutathione (Desideri et al., 
2012; Filomeni et al., 2015). Oxidized proteins become then a target of autophagy so 
amino acids can enter the tricarboxylic acid cycle to be used to synthesize ATP 
(Desideri et al., 2012; Filomeni et al., 2015). Hence, supplementation with 
antioxidants needs to be carefully designed. The elderly constitute that rancid 
population with high levels of inflammation and oxidative damage to which Bast and 
Haenen referred (Bast and Haenen, 2013). In the elderly, and in the appropriate 
dose, RV might enhance endothelial function when used as a secondary strategy to a 
balanced diet and regular exercise and thus, contribute to a healthier yet 
unavoidable, aging.  
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Figure Legends 
Figure 1: Schematic representation of the molecular, biochemical and physiological 
effects of RV on the blood vessel. RV activates PCG1-α, SIRT1 and Nfr2 through the 
cAMP-AMPK signaling pathway. Improvements in vasodilation are the consequence 
of enhanced activity of eNOS and antioxidant enzymes, substrate oxidation and 
organelle quality control together with a reduction in ROS and pro-inflammatory 
molecules. During aging, there is a natural decline in autophagy, which results in 
higher levels of oxidative stress, inflammation, and eventually, endothelial 
dysfunction. 
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Table 1. Effects of resveratrol on the blood vessel. 
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Model 
Cells / Tissue Dose and Duration of 
Treatment 
Effects Reference 
in vivo studies 
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rats 
Aorta 10 mg·kg−1·day−1 for 1 
week 
/  NF-κB,   
/  monocyte adhesiveness 
↓ inflammatory gene expression. 
Ungvari  et al., 
2007 
Wistar rats on HFS Aorta 50 and 100 mg/kg bw for 
14 weeks 
↓ gains in BW 
↓  SA-β-gal-positive cells 
↓ HFS-induced increase in ROS 
↓ HFS-induced down-regulation of SIRT1 
Tang et al., 2012 
Male Wistar rats Aorta 0.0015 mg/kg & 4 mg/kg of 
chow for 6 months 
 endothelium-dependent dilation  
 telomere length and telomerase activity 
↓ expression of p53 and p16 
da Luz et al., 
2012a 
Male Wistar Kyoto 
rats 
Aorta 10 µmol/L for 1 hour   NO production 
 endothelium-dependent dilation 
↓ activation of Akt and S6K1 
↓ production of O2•- 
Rajapakse et al., 
2011 
Male ICR wild-type 
mice (Nrf2+/+) 
Arterioles in the 
gracilis muscle 
2.4 g resveratrol per kg diet 
for 16 weeks. 
↓ gains in BW 
 NQO1, GCLC, and HMOX1mRNA 
Ungvari et al., 
2010 
in vitro studies 
Cell culture 
 
 
HCAEC treated 
with high glucose 
10−6 – 10−4 mol/l for 24 h 
 
↓ high glucose-induced mtROS production  Ungvari et al., 
2009 
HCAEC treated 
with high glucose 
10-7 – 10-4 mol/L for 24 h ― vascular ROS production to control levels 
↓ high glucose-induced mitochondrial  O2•- production 
Ungvari et al., 
2010 
BAEC 0.01, 0.1, 1.0, 10 μM for 24 
h 
↓ p47phox 
↓ high glucose-induced ROS production 
Tang et al., 2012 
HUVEC treated 
with H2O2 
50 μM for 48 h ↓ H202-induced down-regulation of SIRT1 
↓  SA-β-gal-positive cells 
↓ ROS production  
/ senescence process  
Kao et al., 2010 
HUVEC 1 μM for 6 days  eNOS and SIRT1 mRNA 
 GABARAP, LC3II and AGT3, MT1X and ANXA2  genes 
Takizawa et al., 
2013 
HUVEC treated 
with TNF-α 
10 μM for 2 h ↓ SQSMT1, ICAM1, PTGS2 and MMP9 protein levels 
 SIRT1, LC3B2 and cAMP concentration 
 MAP1LC3B2–to-actin ratio 
Chen et al., 2013 
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The Effects of Resveratrol on Aging Vessels 
 
Highlights 
 
 Aging is associated with a significant cardiovascular decline.  
 Oxidative stress plays a critical role in such degenerative condition. 
 Oxidative stress leads to compromised autophagy and poor organelle repair. 
 Resveratrol promotes autophagy and protects from oxidative damage and inflammation.  
 Resveratrol bears potential to restore vascular function in the elderly.  
